Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

50.26

-0.86 (-1.68%)

At close: Feb 21, 2025, 4:00 PM

51.00

+0.74 (1.47%)

After-hours: Feb 21, 2025, 5:44 PM EST

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $5.93 billion as of February 21, 2025. Its market cap has decreased by -24.54% in one year.

Market Cap

5.93B

Enterprise Value

5.83B

1-Year Change

-24.54%

Ranking

#1181

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $5.93B, an increase of 1,314.59%. That is a compound annual growth rate of 13.57%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	5.93B	6.85%
Dec 31, 2024	5.55B	-32.19%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings